Immunohistochemical Study on Hormone Receptors and HER2 Status in Invasive Breast Carcinoma and its Therapeutic Implications

Authors

  • Md Iqbal Karim Classified Specialist in Pathology, Department of Histopathology, Jaber Al Ahmed Armed Forces Hospital, Kuwait. Deputation to Medical, OKP-5, Kuwait
  • Md Tarikul Islam Graded Specialist in Surgery, OKP-5, Kuwait
  • Nazlima Nargis Associate Professor, Department of Gynae & Obstetrics, Ibn Sina Medical College, Dhaka

DOI:

https://doi.org/10.3329/bccj.v7i2.43459

Keywords:

Breast carcinoma, Estrogen, Progesterone, HER2, Immunohistochemistry

Abstract

Background: Immunohistochemistry (IHC) has become an integral part of histopathology in the diagnosis of biopsysample. Although haematoxylin and eosin (H & E) stain remains the fundamental basis for diagnostic pathology of thebreast, IHC stains provide useful and sometimes vital information. Moreover, the role of hormonal therapy in hormonereceptor–positive breast tumours, as well as targeted chemotherapeutic agents for human epidermal growth factorreceptor-2 (HER2) positive cases, IHC studies represent a major part of workups.

Objective: The study was carried out to identify the common immunohistochemical markers in invasive breastcarcinoma and to find out the relationship between hormonal receptor status and HER2 over expression with the gradeof tumour and its therapeutic implications.

Method: In the present study, immunohistochemical assay of total seventy-two blocks of breast carcinoma patients wasperformed to know the hormone receptors and HER2 status as well as histological examination.

Result: 72 samples were grouped to study hormonal status and their relation with clinicopathological factors. Outcomeof this study documented 58.33 %, 44.44% and 25 % expression rate of estrogen receptor (ER), progesterone receptor(PR) and human epidermal growth factor receptor-2 (HER2) respectively. The negative expression of HER2 receptorsfound higher (75%) than ER & PR. The ER, PR negative and HER2 Positive cases found in high grade breast cancer(Grade-3). An inverse correlation of HER2 expression with ER and PR expression was observed (p=0.001).

Conclusion: The role of hormone receptors and HER2 repression as a prognostic and therapeutic tool in breast canceris widely accepted and effective for patients.

Bangladesh Crit Care J September 2019; 7(2): 95-98

Downloads

Download data is not yet available.
Abstract
922
PDF
377

Downloads

Published

2019-10-08

How to Cite

Karim, M. I., Islam, M. T., & Nargis, N. (2019). Immunohistochemical Study on Hormone Receptors and HER2 Status in Invasive Breast Carcinoma and its Therapeutic Implications. Bangladesh Critical Care Journal, 7(2), 95–98. https://doi.org/10.3329/bccj.v7i2.43459

Issue

Vol. 7 No. 2 (2019)

Section

Original Articles

License

Upon acceptance for publication the copyright of the paper automatically transfers to the BCCJ and will not be published elsewhere either in part or whole without written permission of the copyright holder.

Except for personal use, no part of the materials published in this journal may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, photocopying, recording or otherwise without the prior written permission of the publisher.